Tidal volume by sevoflurane in small amounts is stable due to the increase in the breathing rate. But alveolus ventilation decreases due to sevoflurane as the degree of sedation increases; this ultimately causes PaCO2 to rise. The occurrence of suppression of breath increases the risk of severe hypoxia and hypercapnia in deeply sedated patients with disabilities. Sevoflurane inhalation anesthesia has a number of risks and may have unexpected problems with hemodynamic changes depending on the underlying state of the body. This study was conducted to examine the stability of internal acid-base system caused by respiratory depression occurring when patients with disabilities are induced by sevoflurane.Anesthetic induction was carried out by placing a mask on top of the patient's face and through voluntary breathing with 4 vol% of sevoflurane, 4 L/min of nitrous oxide, and 4 L/min of oxygen. After the patient's loss of consciousness and muscle relaxation, IV line was inserted by an expert and intravenous blood gas was analyzed by extracting blood from vein.In a deeply sedated state, the average amount of pH of the entire patients was measured as 7.36 ± 0.06. The average amount of PvCO₂ of the entire patients was measured as 48.8 ± 8.50 mmHg. The average amount of HCO₃₋ of the entire patients was measured as 27.2 ± 3.0 mmol/L.In conclusion, in dental treatment of patients with disabilities, the internal acid base response to inhalation sedation using sevoflurane is relatively stable.
Anesthesia, General ; Anesthesia, Inhalation ; Anoxia ; Blood Gas Analysis ; Hemodynamics ; Humans ; Hydrogen-Ion Concentration ; Hypercapnia ; Inhalation ; Masks ; Muscle Relaxation ; Nitrous Oxide ; Oxygen ; Respiration ; Respiratory Insufficiency ; Tidal Volume ; Unconsciousness ; Veins ; Ventilation

PURPOSE: This study aimed to investigate the correlation between the solubility and the amount of fluoride release when a resin surface coating agent is applied to RMGIC. MATERIALS AND METHODS: To measure the fluoride release and solubility, Fuji II LC®and Filtek™ Z350XT without a surface coating, Fuji II LC® with G coat plus™ and Fuji II LC® with Permaseal® were prepared. And the amount of fluoride release and solubility were measured. RESULTS: There was no significant difference in the daily fluoride release between the surface coating agents. The cumulative fluoride release was significantly different between the groups using RMGIC at 56 days (P < 0.05). In the solubility measurement, RMGIC without surface coating was significantly different only on the 7th day compared to the other three groups (P < 0.05). CONCLUSION: Surface coating agents can prevent the degradation of properties by the initial solvent in RMGIC. Therefore, fluoride is preserved inside the restorative material and the effect of surface coating after the addition is reduced, so that the effect on fluoride release and storage is also reduced.
Fluorides ; Glass ; Solubility

No abstract available.
Humans ; Recurrent Laryngeal Nerve* ; Thyroid Gland* ; Vocal Cord Paralysis*

Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor, with a low-grade malignant potential, occurring predominantly in children and young adults. Association between AFH and other malignancies has been rarely reported. A 27-year-old man who presented with a palpable abdominal mass was diagnosed as having testicular cancer with multiple liver and lung metastases. At 16 months after chemotherapy, a follow-up computed tomographic scan revealed a supraclavicular mass measuring 3 cm in size, which was suspected to be a recurrence. The patient underwent surgical excision, and the mass was pathologically diagnosed as a AFH. The patient has had no local recurrence and no distant metastasis for 12 months after resection. To the best of our knowledge, this is the first case report of AFH as a second tumor in a patient with testicular cancer.
Adult ; Child ; Follow-Up Studies ; Histiocytoma ; Histiocytoma, Benign Fibrous ; Humans ; Liver ; Lung ; Neoplasm Metastasis ; Neoplasms, Second Primary ; Recurrence ; Testicular Neoplasms ; Young Adult

Myxoma of the aortic valve is an exceedingly uncommon condition. In this article, we report the case of a 72-year-old man with myxoma arising from the aortic valve. We extirpated the mass and repaired the aortic valve with the patient under cardiopulmonary bypass. The postoperative course was uneventful. Histological examination confirmed that the mass was a myxoma.
Aged ; Aortic Valve ; Cardiopulmonary Bypass ; Humans ; Myxoma